The cryptophycins: Their synthesis and anticancer activity

被引:91
作者
Eggen, M
Georg, GI [1 ]
机构
[1] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA
[2] Pharmacia Corp, Kalamazoo, MI 49001 USA
关键词
cryptophycin; synthesis; antimitotic; cancer;
D O I
10.1002/med.10002
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The cryptophycins are a unique family of 16-membered macrolide antimitotic agents isolated from the cyanobacteria Nostoc sp. Their molecular target is tubulin protein wherein they are the most potent known stabilizers of microtubule dynamics and depolymerize microtubules at higher concentrations, They also deactivate the Bcl2 protein and produce apoptotic response much more quickly and at considerably lower concentrations than clinically utilized compounds. The presence of several amide and ester link-ages within the cryptophycin core provides access to very convergent total synthetic approaches. Likewise, the modularity of the structure renders their synthesis amenable to structure-activity studies in several regions of the molecule. The in vivo hydrolytic instability of the C5 ester was a key obstacle to the successful identification of a clinical candidate. This problem was ameliorated by increased substitution at C6 as in the presence of gem-dimethyl substitution in the clinical candidate, cryptophycin-52, (C) 2002 John Wiley Sons, Inc.
引用
收藏
页码:85 / 101
页数:17
相关论文
共 64 条
  • [1] ALAWAR RS, 1997, P AM ASSOC CANC RES, V39, P425
  • [2] Formal syntheses of cryptophycin A and arenastatin A
    Ali, SM
    Georg, GI
    [J]. TETRAHEDRON LETTERS, 1997, 38 (10) : 1703 - 1706
  • [3] [Anonymous], [No title captured], Patent No. [WO9640184A1, 9640184]
  • [4] [Anonymous], [No title captured], Patent No. [US4946835, 4946835]
  • [5] Bai RL, 1996, CANCER RES, V56, P4398
  • [6] TOTAL SYNTHESIS OF CRYPTOPHYCINS - REVISION OF THE STRUCTURES OF CRYPTOPHYCIN-A AND CRYPTOPHYCIN-C
    BARROW, RA
    HEMSCHEIDT, T
    LIANG, J
    PAIK, S
    MOORE, RE
    TIUS, MA
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1995, 117 (09) : 2479 - 2490
  • [7] Chakraborty TK, 1999, J INDIAN CHEM SOC, V76, P611
  • [8] Chen BDM, 1998, INT J CANCER, V77, P869, DOI 10.1002/(SICI)1097-0215(19980911)77:6<869::AID-IJC12>3.0.CO
  • [9] 2-X
  • [10] Christopher JA, 2000, SYNLETT, P463